Home/Filings/4/0001415889-21-002207
4//SEC Filing

Cherevka Holli 4

Accession 0001415889-21-002207

CIK 0001411906other

Filed

Apr 28, 8:00 PM ET

Accepted

Apr 29, 9:36 PM ET

Size

13.3 KB

Accession

0001415889-21-002207

Insider Transaction Report

Form 4
Period: 2021-04-27
Cherevka Holli
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-04-27$0.51/sh+30,000$15,30030,000 total
  • Exercise/Conversion

    Common Stock

    2021-04-27$0.51/sh+44,631$22,76274,631 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-04-27$0.51/sh30,000$15,3000 total
    Exercise: $0.51Exp: 2027-08-08Common Stock (30,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-04-27$0.51/sh44,631$22,762155,369 total
    Exercise: $0.51Exp: 2029-09-16Common Stock (44,631 underlying)
  • Sale

    Common Stock

    2021-04-27$2.00/sh74,631$149,2620 total
Footnotes (4)
  • [F1]The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 12, 2021.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.005, inclusive. The reporting person undertakes to provide to Ampio Pharmaceuticals, Inc., any security holder of Ampio Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  • [F3]Options were granted and previously reported on a Form 4 filed on September 21, 2017, where all of the options reported vested and became exercisable immediately.
  • [F4]Options were granted and previously reported on a Form 4 filed on September 18, 2019, where 50% of the options awarded vested and became exercisable on the grant date of September 16, 2019 and the other 50% of the options awarded vested and became exercisable on the first anniversary of the grant date.

Issuer

Ampio Pharmaceuticals, Inc.

CIK 0001411906

Entity typeother

Related Parties

1
  • filerCIK 0001717673

Filing Metadata

Form type
4
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 9:36 PM ET
Size
13.3 KB